Relationships between the catechol substrate binding site and amphetamine, cocaine, and mazindol binding sites in a kinetic model of the striatal transporter of dopamine in vitro

Journal of Neurochemistry

Volumn 70, Issue 5, 1998, Pages 1941-1949

  Wayment, Hollie ^a   Meiergerd, Susan M ^a,b   Schenk, James O ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Amphetamine binding site; Catechol substrate binding site; Cocaine binding site; M Tyramine; Mazinol binding site; Phenethylamines; Rotating disk electrode voltammetry; Striatal dopamine transporter

Indexed keywords

AMPHETAMINE; CATECHOL; COCAINE; DOPAMINE TRANSPORTER; MAZINDOL; PHENETHYLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; ELECTRODE; ENZYME ACTIVITY; ENZYME SUBSTRATE; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031958698     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70051941.x     Document Type: Article

References (37)

1. 3H-norepinephrine from isolated brain tissue. J. Pharmacol. Exp. Ther. 189, 110-118.
2. Carroll F. I., Lewin A. H., Boja J. W., and Kuhar M. J. (1992) Cocaine receptor: biochemical characterization and structure activity relationships of cocaine analogues at the dopamine transporter. J. Med. Chem. 35, 969-981.
3. Chait L. D., Uhlenhuth E. H., and Johansen C. E. (1987) Reinforcing and subjective effects of several anorectics in normal human volunteers. J. Pharmacol. Exp. Ther. 242, 777-783.
4. Coyle J. T. and Snyder S. H. (1969) Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science 166, 899-901.
5. Devés R. and Krupka R. M. (1980) Testing transport systems for competition between pairs of reversible inhibitors: inhibition of erythrocyte glucose transport by cytochalasin B and steroids. J Biol. Chem. 255, 11870-11874.
6. Devés R. and Krupka R. M. (1989) Inhibition kinetics of carrier systems. Methods Enzymol 171, 113-132.
7. Eshelman A. J., Henningsen R. A., Neve K. A., and Janowsky A. (1994) Release of dopamine via the human transporter. Mol. Pharmacol. 45, 312-316.
8. Fersht A. (1985) Enzyme Structure and Mechanism. 2nd edit. W. H. Freeman and Co., New York.
9. Fischer J. F., and Cho A. K. (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol. Exp. Ther. 208, 203-209.
10. Giros B., Wang Y.-M, Suter S., McLeskey S. B., Pifl C., and Caron M. (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimenc dopamine-norepinephrine transporters. J. Biol. Chem. 269, 15985-15988.
11. Havilcek L. L. and Crane R. D. (1988) Practical Statistics for the Physical Sciences. American Chemical Society, Washington, D.C.
12. Horn A. S. (1979) Characteristics of dopamine uptake, in The Neurobiology of Dopamine (Horn A. S., Korf J., and Westerink B. H. C., eds), pp. 217-235. Academic Press, London.
13. Horn A. S., Coyle J. T., and Snyder S. H. (1970) Catecholamine uptake by synaptosomes from rat brain: structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. Mol. Pharmacol. 7, 66-80.
14. 3H] mazindol binding sites from alkylation by N-ethylmaleimide. Eur. J. Pharmacol. 227, 411-415.
15. 3H] dopamine from isolated corpus striatum by amphetamine, fenfluramine, and unlabelled dopamine. Biochem. Pharmacol. 31, 983-992.
16. Liang N. Y. and Rutledge C. O. (1982b) Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem. Pharmacol. 31, 2479-2484.
17. McElvain J. S. and Schenk J. O. (1992) A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem. Pharmacol. 43, 2189-2199.
18. Meiergerd S. M. and Schenk J. O. (1994) Kinetic evaluation of the commonality between the site(s) of action of cocaine and some structurally similar and dissimilar inhibitors of the striatal transporter for dopamine. J. Neurochem. 63, 1683-1692.
19. Meiergerd S. M. and Schenk J. O. (1995) Measurement of the time-resolved kinetics of biogenic amine release and transporter activity by rotating disk electrode voltammetry in vitro, in Neuromethods, Vol. 27: Voltammetric Methods in Brain Systems (Boulton A., Baker G., and Adams R. N., eds), pp. 305-337. Humana Press, Totowa, New Jersey.
20. Missale C., Catelletti L., Govoni S., Spano P. F., Trabbuchi M., and Hanbauer I. (1985) Dopamine uptake is differentially regulated in the rat striatum and nucleus accumbens. J. Neurochem. 45, 51-56.
21. Niddam R., Arbilla S., Scatton B., Dennis T., and Langer Z. (1985) Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine. Naunyn Schmiedebergs Arch. Pharmacol. 329, 123-127.
22. Parker E. M. and Cubeddu L. X. (1986a) Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. J. Pharmacol. Exp. Ther. 237, 179-192.
23. Parker E. M. and Cubeddu L. X. (1986b) Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. J. Pharmacol. Exp. Ther. 237, 193-203.
24. Paton D. M., ed (1976) The Mechanism of Neuronal and Extraneuronal Transport of Catecholamines. Raven Press, New York.
25. Patterson T. A. and Schenk J. O. (1991) Effects of acute and chronic administration of some typical antipsychotic drugs on dopamine turnover and potassium ion induced release of dopamine in the striatum of the rat in vivo. Neuropharmacology 30, 943-950.
26. Petrali E. H., Boulton A. A., and Dyck L. E. (1979) Uptake of paratyramine and mew-tyramine in slices of the caudate nucleus and hypothalamus of the rat. Neurochem. Res. 4, 633-642.
27. Pifl C., Drobny H., Reither H., Hornykiewicz O., and Singer E. A. (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol. Pharmacol. 47, 368-373.
28. Reith M. E. A. and Selmeci G. (1992) Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935. Naunyn Schmiedebergs Arch. Pharmacol. 345, 309-318.
29. Reith M. E. A., de Costa B., Rice K. C., and Jacobsen A. E. (1992) Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12835 and dopamine to the dopamine transporter. Eur. J. Pharmacol. Mol. Pharmacol. 227, 417-425.
30. Ritz M. C., Lamb R. J., Goldberg S. R., and Kuhar M. J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
31. Segel I. H. (1993) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, pp. 136-143. Wiley Classics Library Edition, John Wiley & Sons, New York.
32. Stein W. D. (1986) Transport and Diffusion Across Cell Membranes, pp. 231-361. Academic Press, San Diego.
33. Stein W. D. (1990) Channels, Carriers, and Pumps: An Introduction to Membrane Transport, pp. 133-143. Academic Press, San Diego.
34. Wall S. C., Gu H., and Rudnick G. (1996) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. J. Mol. Pharmacol. 47, 544-550.
35. Wayment H. K. and Schenk J. O. (1996) Relationships between catechol substrate binding site and amphetamine and cocaine binding sites in a kinetic model of the striatal transport of dopamine. Soc. Neurosci. Abstr. 22, 370.
36. 3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration. J. Pharmacol. Exp. Ther. 257, 820-829.
37. 3H]amphetamine with rat brain synaptosomes. II. Active transport. J. Pharmacol. Exp. Ther. 257, 830-835.